KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,901 | -19.4% | 6,490 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $256,750 | -5.6% | 6,390 | +0.3% | 0.00% | 0.0% |
| Q1 2023 | $271,999 | -11.1% | 6,370 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $305,887 | -1.0% | 6,370 | -22.4% | 0.00% | 0.0% |
| Q3 2022 | $309,000 | +36.1% | 8,210 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $227,000 | -35.0% | 8,210 | +28.1% | 0.00% | 0.0% |
| Q1 2022 | $349,000 | -6.9% | 6,410 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $375,000 | +47.6% | 6,410 | 0.0% | 0.00% | – |
| Q3 2021 | $254,000 | -6.6% | 6,410 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $272,000 | +5.0% | 6,410 | +52.6% | 0.00% | 0.0% |
| Q1 2021 | $259,000 | -12.5% | 4,200 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $296,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |